Vir Biotechnology, Inc. (VIR)
11.70
+0.58
(+5.22%)
USD |
NASDAQ |
Oct 09, 16:00
11.55
-0.15
(-1.28%)
After-Hours: 04:05
Vir Biotechnology Net Income (Quarterly) : 80.08M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 80.08M |
| March 31, 2026 | -125.70M |
| December 31, 2025 | -42.92M |
| September 30, 2025 | -163.14M |
| June 30, 2025 | -110.96M |
| March 31, 2025 | -120.96M |
| December 31, 2024 | -104.59M |
| September 30, 2024 | -213.72M |
| June 30, 2024 | -138.38M |
| March 31, 2024 | -65.28M |
| December 31, 2023 | -115.97M |
| September 30, 2023 | -163.41M |
| June 30, 2023 | -194.78M |
| March 31, 2023 | -140.96M |
| December 31, 2022 | -101.60M |
| September 30, 2022 | 175.31M |
| Date | Value |
|---|---|
| June 30, 2022 | -76.49M |
| March 31, 2022 | 518.62M |
| December 31, 2021 | 525.25M |
| September 30, 2021 | 110.43M |
| June 30, 2021 | 61.81M |
| March 31, 2021 | -168.91M |
| December 31, 2020 | -105.65M |
| September 30, 2020 | -84.61M |
| June 30, 2020 | -31.17M |
| March 31, 2020 | -77.24M |
| December 31, 2019 | -63.77M |
| September 30, 2019 | -48.31M |
| June 30, 2019 | -33.93M |
| March 31, 2019 | -28.67M |
| December 31, 2018 | -26.39M |
| September 30, 2018 | -33.46M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Moderna, Inc. | -782.00M |
| Vaxcyte, Inc. | -284.30M |
| Caribou Biosciences, Inc. | -24.28M |
| Arrowhead Pharmaceuticals, Inc. | -178.92M |
| Oncolytics Biotech, Inc. | -9.442M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 238.95M |
| Total Expenses (Quarterly) | 158.87M |
| EPS Diluted (Quarterly) | 0.4742 |
| Enterprise Value | 1.538B |
| Gross Profit Margin (Quarterly) | 98.83% |
| Profit Margin (Quarterly) | 33.51% |
| Earnings Yield | -15.91% |
| Normalized Earnings Yield | -15.76 |